Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

ANTINICOTINIC ACTION OF BENZYLTRIMETHYLAMMONIUM BROMIDE (BTM)

KENNETH DRETCHEN, M. D. SOKOLL and J. P. LONG
Journal of Pharmacology and Experimental Therapeutics July 1971, 178 (1) 192-198;
KENNETH DRETCHEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. D. SOKOLL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. P. LONG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The blocking action of benzyltrimethylammonium bromide (BTM) was studied with various nicotinic preparations. On the superfused frog rectus abdominis muscle preparations the compound blocked responses to acetylcholine, nicotine and KCl. Doubling the potassium in the bathing solution negated the BTM effect. BTM caused inhibition of the rabbit sciatic nerve gastrocnemius muscle preparation and the blockade was potentiated by neostigmine and not affected by calcium or choline. The compound also blocked the chick biventer cervicis muscle preparation. The blockade was potentiated by neostigmine and offset by doubling the potassium in the external medium. BTM decreased the sensitivity to iontophoretically applied acetylcholine and miniature end-plate potential amplitude. It decreased the resting membrane potentials of both innervated and denervated muscles and blocked the action potentials of both innervated and denervated muscles and blocked the action potential only in high concentrations. BTM is thought to have a dual mechanism of action, a depolarizing type of blockade at lower doses and a blocking action induced by potassium effiux from the cell at higher dose levels.

Footnotes

    • Received January 22, 1971.
    • Accepted March 31, 1971.
  • © 1971, by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 178, Issue 1
1 Jul 1971
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ANTINICOTINIC ACTION OF BENZYLTRIMETHYLAMMONIUM BROMIDE (BTM)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

ANTINICOTINIC ACTION OF BENZYLTRIMETHYLAMMONIUM BROMIDE (BTM)

KENNETH DRETCHEN, M. D. SOKOLL and J. P. LONG
Journal of Pharmacology and Experimental Therapeutics July 1, 1971, 178 (1) 192-198;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

ANTINICOTINIC ACTION OF BENZYLTRIMETHYLAMMONIUM BROMIDE (BTM)

KENNETH DRETCHEN, M. D. SOKOLL and J. P. LONG
Journal of Pharmacology and Experimental Therapeutics July 1, 1971, 178 (1) 192-198;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Pharmacological Characterization of Nicotine-Induced Seizures in Mice
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics